- Home
- HCWB vs RUBI Comparison
HCWB vs RUBI Comparison
Compare HCWB & RUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCWB | RUBI |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Marshall Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 3.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HCWB | RUBI |
|---|---|---|
| Price | $1.36 | $0.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 56.3K | ★ 808.0K |
| Earning Date | 11-14-2025 | 05-06-2020 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $422,026.00 | ★ $24,139,000.00 |
| Revenue This Year | $178.64 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.95 | $0.77 |
| 52 Week High | $41.20 | $200.70 |
Technical Indicators
Market Signals| Indicator | HCWB | RUBI |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | N/A |
| Support Level | $1.10 | N/A |
| Resistance Level | $1.35 | N/A |
| Average True Range (ATR) | 0.13 | 0.00 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 89.07 | 0.00 |
Price Performance
Historical ComparisonAbout HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About RUBI Rubico Inc.
Rubico Inc operates as a holding company. It is an eco-conscious international crude oil shipping company. The company's primary business is the ownership and operation of an eco-conscious fleet of tanker vessels designed for enhanced fuel efficiency, reduced greenhouse emissions, and a wide range of environmentally friendly technologies.